CJC-1295 With DAC

Explore CJC-1295 With DAC at Peptide Insight and find essential information about this synthetic peptide. This listing helps customers review product identity, available strengths, packaging and supporting documentation before making an informed purchasing decision.

The compound belongs to the growth hormone-releasing hormone analogue family. Its Drug Affinity Complex (DAC) modification allows it to bind albumin, distinguishing it from the version without DAC.

CJC-1295 With DAC Product Overview

This listing focuses specifically on the DAC-containing formulation.

Before selecting a product, confirm its chemical identity, labelled quantity and manufacturer’s information. Additionally, review the product specifications to distinguish it from Modified GRF (1-29), commonly marketed as the version without DAC.

Explore our Peptide Products collection to compare related listings and their individual characteristics.

Product Specifications and Available Strengths

Accurate information helps customers identify the correct material.

Review these essential details:

• Product name: CJC-1295 With DAC
• Compound: GHRH analogue with DAC modification
• Strength: Confirm from the actual product label
• Form: Confirm from the packaging
• Package contents: Verify the supplied quantity
• Manufacturer: Confirm supplier information
• Storage: Follow documented manufacturer instructions

Furthermore, check the batch number and expiration date when applicable.

Visit the Peptide Insight shop to explore other available products.

CJC-1295 Product Quality and Documentation

Reliable product information begins with accurate identification.

First, examine the manufacturer’s specifications and available analytical documentation.

Next, review any certificate of analysis and confirm that it corresponds to the actual product batch.

Moreover, verify purity and testing claims before including them in a product listing.

For additional website information, visit Peptide Insight.

CJC-1295 Safety Information

CJC-1295 is not an FDA-approved medicine. The FDA has identified potential safety concerns, including immune reactions, peptide-related impurities, increased heart rate and systemic vasodilatory reactions.

Although early human studies investigated its hormonal effects, those findings do not establish clinical safety or effectiveness for independently supplied products.

Consult the published human CJC-1295 study for further scientific information.

Product Availability and Customer Support

Before ordering, confirm the exact formulation, product documentation and applicable legal requirements.

If important specifications remain unclear, contact the supplier for clarification.

This listing does not establish the product as safe or effective for human administration.